Relationship between severity of prevalent vertebral fractures and risk of subsequent nonvertebral fractures in postmenopausal women with osteoporosis: Results from the more trial

被引：0
|
作者：
Delmas, PD
Genant, H
Crans, G
Stock, J
Wong, M
Siris, E
Adachi, J
机构：
[1] Univ Lyon 1, Hop Edouard Herriot, F-69365 Lyon, France
[2] Univ Calif San Francisco, Osteoporosis & Arthritis Res Grp, San Francisco, CA 94143 USA
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[4] Columbia Univ, Dept Med, New York, NY USA
[5] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [1] Relationship between severity of prevalent vertebral fractures and risk of subsequent nonvertebral fractures in postmenopausal women with osteoporosis: Results from the MORE trial
    Delmas, P
    Genant, H
    Crans, G
    Stock, J
    Wong, M
    Siris, E
    Adachi, J
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S38 - S39
  • [2] Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial
    Delmas, PD
    Genant, HK
    Crans, GG
    Stock, JL
    Wong, M
    Siris, E
    Adachi, JD
    BONE, 2003, 33 (04) : 522 - 532
  • [3] Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial
    Hagino, Hiroshi
    Shiraki, Masataka
    Fukunaga, Masao
    Nakano, Tetsuo
    Takaoka, Kunio
    Ohashi, Yasuo
    Nakamura, Toshitaka
    Matsumoto, Toshio
    JOURNAL OF BONE AND MINERAL METABOLISM, 2013, 31 (05) : 544 - 550
  • [4] Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial
    Hiroshi Hagino
    Masataka Shiraki
    Masao Fukunaga
    Tetsuo Nakano
    Kunio Takaoka
    Yasuo Ohashi
    Toshitaka Nakamura
    Toshio Matsumoto
    Journal of Bone and Mineral Metabolism, 2013, 31 : 544 - 550
  • [5] NUMBER AND SEVERITY OF PREVALENT VERTEBRAL FRACTURES AND THE RISK OF SUBSEQUENT VERTEBRAL FRACTURES IN JAPANESE WOMEN WITH ESTABLISHED OSTEOPOROSIS: RESULTS FROM THE MINODRONATE TRIAL
    Hagino, H.
    Shiraki, M.
    Fukunaga, M.
    Nakano, T.
    Takaoka, K.
    Ohashi, Y.
    Nakamura, T.
    Matsumoto, T.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S818 - S819
  • [6] Prevalent vertebral fracture severity predicts subsequent vertebral and nonvertebral fracture risk in postmenopausal women with osteoporosis: Results from the multiple outcomes of raloxifene evaluation (MORE) trial
    Delmas, P
    Genant, H
    Crans, G
    Siris, E
    Wong, M
    Sarkar, S
    Stock, J
    Harper, K
    Adachi, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 521 - 521
  • [7] Prevalent vertebral fracture severity predicts subsequent vertebral and nonvertebral fracture risk in postmenopausal women with osteoporosis: Results from the multiple outcomes of raloxifene evaluation (more) trial
    Delmas, P
    Genant, H
    Crans, G
    Siris, E
    Wong, M
    Sarkar, S
    Stock, J
    Harper, K
    Adachi, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13
  • [8] Treatment with raloxifene reduces the incidence of new vertebral fractures in postmenopausal women with prevalent nonvertebral baseline fractures: Results from the more trial
    Fardellone, P
    Cohen-Solal, M
    Sarkar, S
    Pinette, K
    Liu-Leage, S
    Seeman, E
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S21 - S22
  • [9] Effects of raloxifene on the severity of new vertebral fractures in postmenopausal women with osteoporosis: Results from the MORE trial.
    Siris, E
    Crans, G
    Sarkar, S
    Wong, M
    Harper, KD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S291 - S291
  • [10] Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis
    Krege, J. H.
    Wan, X.
    BONE, 2012, 50 (01) : 161 - 164
12345